| Source: |
| Type: |
| cPLA2 is a key enzyme that hydrolyzes membrane phospholipids to release arachidonic acid, serving as the precursor for the synthesis of eicosanoids (prostaglandins, leukotrienes, etc.). These lipid mediators can significantly influence inflammation, cell proliferation, survival, angiogenesis, and metastasis—all processes that are critical in cancer development and progression. cPLA2 plays a multifaceted role in carcinogenesis through its involvement in the production of bioactive lipids that regulate inflammation, cell growth, and metastasis. Its expression is frequently elevated in several cancers—including breast, prostate, colorectal, lung, ovarian, and head and neck cancers—and is generally associated with a poorer prognosis. |
| - | in-vitro, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1027 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid